- $4.70bn
- $11.67bn
- $2.83bn
- 51
- 80
- 30
- 53
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,088 | 3,152 | 2,556 | 2,575 | 2,832 |
Cost of Revenue | |||||
Gross Profit | 948 | 1,152 | 859 | 896 | 846 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,850 | 3,112 | 2,617 | 2,598 | 3,188 |
Operating Profit | -762 | 40 | -61 | -23 | -356 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1,198 | -541 | -470 | -562 | -941 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,257 | -568 | -591 | -621 | -954 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1,255 | -567 | -592 | -621 | -954 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,255 | -567 | -592 | -621 | -954 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.35 | -0.647 | -0.88 | -0.887 | -1.01 |